Frank A. Pigula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Frank A. Pigula has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ellen Tunney Roche
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, USA
3 shared publications Christopher J. Payne
John A. Paulson Harvard School of Engineering and Applied Science, Harvard University , Cambridge, Massachusetts
2 shared publications- Conor James Walsh
Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA
2 shared publications Isaac Wamala
Boston Children's Hospital , Harvard Medical School, Boston, Massachusetts
2 shared publicationsMarkus A. Horvath
John A. Paulson Harvard School of Engineering and Applied Science, Harvard University , Cambridge, Massachusetts
2 shared publicationsNikolay V. Vasilyev
Boston Children's Hospital , Harvard Medical School, Boston, Massachusetts
2 shared publications
Latest Publications
- 1 September 2017
- Published by SAGE Publications in Soft Robotics
- Vol. 4 (3) , 241-250
An Implantable Extracardiac Soft Robotic Device for the Failing Heart: Mechanical Coupling and Synchronization
Soft robotic devices have significant potential for medical device applications that warrant safe synergistic interaction with humans. This article describes the optimization of an implantable soft robotic system for heart failure whereby soft actuators wrapped around the ventricles are programmed to contract and relax in synchrony with the beating heart. Elastic elements integrated in to the soft actuators provide recoiling function so as to aid refilling during the diastolic phase of the cardiac cycle. Improved synchronization with the biological system is achieved by incorporating the native ventricular pressure in to the control system to trigger assistance and synchronize the device with the heart. A three-state electro-pneumatic valve configuration allows the actuators to contract at different rates to vary contraction patterns. An in vivo study was performed to test three hypotheses relating to mechanical coupling and temporal synchronization of the actuators and heart. First, that adhesion of the actuators to the ventricles improves cardiac output. Second, that there is a contraction–relaxation ratio of the actuators which generates optimal cardiac output. Third, that the rate of actuator contraction is a factor in cardiac output.
- 1 September 2017
- Published by SAGE Publications in Soft Robotics
- Vol. 4 (3) , 241-250
An Implantable Extracardiac Soft Robotic Device for the Failing Heart: Mechanical Coupling and Synchronization
Soft robotic devices have significant potential for medical device applications that warrant safe synergistic interaction with humans. This article describes the optimization of an implantable soft robotic system for heart failure whereby soft actuators wrapped around the ventricles are programmed to contract and relax in synchrony with the beating heart. Elastic elements integrated in to the soft actuators provide recoiling function so as to aid refilling during the diastolic phase of the cardiac cycle. Improved synchronization with the biological system is achieved by incorporating the native ventricular pressure in to the control system to trigger assistance and synchronize the device with the heart. A three-state electro-pneumatic valve configuration allows the actuators to contract at different rates to vary contraction patterns. An in vivo study was performed to test three hypotheses relating to mechanical coupling and temporal synchronization of the actuators and heart. First, that adhesion of the actuators to the ventricles improves cardiac output. Second, that there is a contraction–relaxation ratio of the actuators which generates optimal cardiac output. Third, that the rate of actuator contraction is a factor in cardiac output.
- 16 August 2017
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 15 (10) , 767-774
The use of soft robotics in cardiovascular therapy
Introduction: Robots have been employed in cardiovascular therapy as surgical tools and for automation of hospital systems. Soft robots are a new kind of robot made of soft deformable materials, that are uniquely suited for biomedical applications because they are inherently less likely to injure body tissues and more likely to adapt to biological environments. Awareness of the soft robotic systems under development will help promote clinician involvement in their successful clinical translation. Areas covered: The most advanced soft robotic systems, across the size scale from nano to macro, that have shown the most promise for clinical application in cardiovascular therapy because they offer solutions where a clear therapeutic need still exists. We discuss nano and micro scale technology that could help improve targeted therapy for cardiac regeneration in ischemic heart disease, and soft robots for mechanical circulatory support. Additionally, we suggest where the gaps in the technology currently lie. Expert commentary: Soft robotic technology has now matured from the proof-of-concept phase to successful animal testing. With further refinement in materials and clinician guided application, they will be a useful complement for cardiovascular therapy.
- 16 August 2017
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 15 (10) , 767-774
The use of soft robotics in cardiovascular therapy
Introduction: Robots have been employed in cardiovascular therapy as surgical tools and for automation of hospital systems. Soft robots are a new kind of robot made of soft deformable materials, that are uniquely suited for biomedical applications because they are inherently less likely to injure body tissues and more likely to adapt to biological environments. Awareness of the soft robotic systems under development will help promote clinician involvement in their successful clinical translation. Areas covered: The most advanced soft robotic systems, across the size scale from nano to macro, that have shown the most promise for clinical application in cardiovascular therapy because they offer solutions where a clear therapeutic need still exists. We discuss nano and micro scale technology that could help improve targeted therapy for cardiac regeneration in ischemic heart disease, and soft robots for mechanical circulatory support. Additionally, we suggest where the gaps in the technology currently lie. Expert commentary: Soft robotic technology has now matured from the proof-of-concept phase to successful animal testing. With further refinement in materials and clinician guided application, they will be a useful complement for cardiovascular therapy.
- Top Cited Papers
- 18 January 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (373)
Soft robotic sleeve supports heart function
A soft robotic sleeve modeled on the structure of the human heart assists cardiovascular function in an ex vivo and in vivo porcine model of heart failure.
- 18 January 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (373)
Top Cited PapersSoft robotic sleeve supports heart function
A soft robotic sleeve modeled on the structure of the human heart assists cardiovascular function in an ex vivo and in vivo porcine model of heart failure.
- 1 January 2017
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 29 (1) , 64-69
Management of Tricuspid Regurgitation in Patients With Hypoplastic Left Heart Syndrome
- 1 January 2017
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 29 (1) , 64-69
Management of Tricuspid Regurgitation in Patients With Hypoplastic Left Heart Syndrome